Caitlin A. Kierum

KKR in its investment in Cotiviti

General Catalyst and Health Assurance Transformation, LLC (HATCo) on the proposed combination of Summa Health with HATCo

Peak Rock Capital-backed Paragon Healthcare, a provider of ambulatory and home infusion services, in its sale to Elevance Health (NYSE: ELV)

Vertava Health of Mississippi, a provider of addiction treatment and mental health services, in its sale to Bradford Health Services

Cressey & Company in the acquisition of HealthDrive, a provider of clinical services to patients residing in long-term care facilities, from Bain Capital Double Impact

Nordic Capital in its acquisition of IntegriChain, a platform for pharma commercialization and market access, from Accel-KKR

AbbVie in its proposed $8.7 billion acquisition of Cerevel Therapeutics

Eli Lilly in its $1.4 billion acquisition of POINT Biopharma Global Inc.

Madison Dearborn Partners and Thoma Bravo in their $1.4 billion sale of Syntellis Performance Solutions to Roper Technologies (NASDAQ: ROP)

Bain Capital Insurance in its investment in Aptia, a provider of employee benefits and pensions administration service

Genesis Care Pty Ltd and its affiliates in their Chapter 11 cases. GenesisCare is a leading cancer care provider, offering personalized and accessible treatment across a network of highly-skilled healthcare professionals to patients globally. GenesisCare is one of the world’s largest integrated oncology organizations and the world’s largest provider of radiotherapy, operating more than 400 cancer centers in the U.S., Australia, Spain and the UK which treat more than 450,000 patients annually. As of its Chapter 11 filing, GenesisCare’s funded debt totaled approximately $1.7 billion, including approximately $1.55 billion in secured term loan indebtedness. GenesisCare commenced its Chapter 11 cases to obtain access to debtor-in-possession financing, to conduct a marketing and sale process for its U.S. assets, and to restructure its financial obligations

Envision Healthcare Corp. and 216 of its affiliates in the commencement of pre-arranged Chapter 11 cases. Envision is a leading national medical group that employs or partners with more than 21,000 clinicians and provides care to patients across the U.S., with nearly 30 million patient visits each year. The two restructuring support agreements contemplate a collective deleveraging of approximately $7.4 billion of secured and unsecured debt and the separation of Envision’s physician services and ambulatory surgical center businesses

Bain Capital-backed U.S. Renal Care, the nation’s largest privately held kidney care provider, on liability management transactions that injected $328 million of new money liquidity into the company’s balance sheet

MultiPlan Corp. (NYSE: MPLN) in its $160 million acquisition of Benefits Science, a data and advanced analytics company

Oak Street Health (NYSE: OSH) in its $10.6 billion sale to CVS Health (NYSE: CVS)

Waters Corporation in its $1.36 billion acquisition of Wyatt Technology

Pipeline Health System, LLC and its affiliates during their Chapter 11 cases. Pipeline Health operates seven “safety net” hospitals, three health clinics and three medical group centers across California, Texas and Illinois, including Weiss Memorial Hospital and West Suburban Medical Center in Chicago

Law Clerk, University of Michigan Office of the Vice President and General Counsel (Michigan Medicine)

Legal Intern, Jackson National Life Insurance

Summer Associate, Kirkland & Ellis LLP

Contracts & Compliance Intern, Valued Relationships, Inc.